The 81st Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Morning Seminar

MS3-14 Essential Role of Factor VIII therapy for Hemophilia A

Sun. Oct 13, 2019 7:55 AM - 8:40 AM No.14 (Tokyo International Forum, 6F G610)

Chair: Yasuharu Nishida（Division of Infectious Disease, Osaka National Hospital）

Sponsor: Takeda Pharmaceutical Company Limited

[MS3-14] Essential Role of Factor VIII therapy for Hemophilia A

Yushi Chikasawa (Department of Laboratory Medicine, Tokyo Medical University)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.Password is written on a program book.

Password